Method for synthesizing chiral ilaprazole
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHENZHEN HUAXIAN PHARMA TECH CO LTD
- Publication Date
- 2018-11-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The invention belongs to the technical field of pharmacy, and specifically relates to a new process route of optically active ilaprazole. Background technique
[0002] Ilaprazole is a proton pump inhibitor developed and marketed by Livzon Group, with the trade name "Yilian". It belongs to a class 1 new drug and is used to treat duodenal ulcers.
[0003] Other proton pump inhibitor drugs, such as omeprazole, lansoprazole, pantoprazole, and rabeprazole, have corresponding single chiral compounds on the market, namely esomeprazole and dextran Soprazole, levopantoprazole, and dexrabeprazole. However, ilaprazole is currently used in medicine as a racemate, and its single chiral compound has not been reported yet.
[0004]
[0005] When a chiral compound enters a living body, its two enantiomers usually exhibit different biological activities. For chiral drugs, one isomer may be effective, while the other isomer may be ineffective or even harmful. For example, the...